A dynamic and high growth biotech company focusing on R&D, production and distribution of Nuclear Medicine (NM) to enhance cancer patients’ quality of life. We are currently supplying radiopharmaceuticals to all the major hospitals with valid licences and will become the only licensed manufacturer in Hong Kong on both cancer diagnostics and therapeutic products in the foreseeable future. Through our strong presence since 2015, we have improved and enhanced the clinical outcome of cancer patients.